It would be more realistic to adopt the Trastuzumab for Gastric Cancer (ToGA) trial scoring method rather than The American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP) guideline recommendations as a reference guide in assessing the HER2 status in our cohort of mucinous ovarian cancer. Here, ERBB2 is linked to gastric cancer.